Tariffs are affecting many industries in 2025, and pharmaceuticals are not being spared. Although new U.S. tariffs on Chinese imports were briefly enacted this year, they were quickly placed on hold. This pause has not eliminated uncertainty. Instead, it has added to the broader sense of economic hesitation, especially in industries like pharmaceuticals that depend […]
Overview Leading global healthcare company determines its manual processes pose high risk for non-compliant clinical labeling content. Implementation of Glemser’s ComplianceAuthor AI system provides automated, validated alternative that ensures accuracy and compliance The Challenge Industry-wide, regulatory authorities have demonstrated increased focus on data integrity. Beyond the need to meet and exceed regulatory standards, non-compliant labeling […]
In the increasingly complex world of global labeling, tracking changes across labeling content is more than a best practice—it’s a regulatory necessity. Health authorities around the globe are demanding more detailed accountability, documentation, and traceability of every change made throughout the product lifecycle. Staying compliant is a major challenge for many companies, especially those with […]
